S. 1364 - Medicaid Generic Drug Price Fairness Act of 2015
- Sponsor:
- Bernard Sanders
- Summary:
- A bill to amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation. (by CRS)
- Status:
- The bill has been referred to committee.
Medicaid Generic Drug Price Fairness Act of 2015
S. 1364 — 114th Congress (2015–2016)
- Summary
- A bill to amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to amend title XIX of the Social Security Act to require the payment of an additional rebate to the State Medicaid plan in the case of increase in the price of a generic drug at a rate that is greater than the rate of inflation.
- Other Titles
- Medicaid Generic Drug Price Fairness Act of 2015
- Medicaid Generic Drug Price Fairness Act of 2015
- Sponsor
- Bernard Sanders
- Co-Sponsors
- Subjects
- Health
- Medicaid
- Prescription drugs
- Related Bills
- Major Actions
Introduced 5/18/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 5/18/2015 5/18/2015 Read twice and referred to the Committee on Finance. 5/18/2015 Introduced in Senate Number Sponsor Date Offered Status
MapLight did not identify any interest groups that took a position on this vote.
You may be able to explore campaign contributions data if you add interest groups.
Contributions data source: OpenSecrets.org